Letter

Hypersensitivity to HPV vaccine

More data from Australia on sensitivity to HPV vaccine

BMJ 2009; 338 doi: 10.1136/bmj.b26 (Published 9 January 2009)
Cite this as: BMJ 2009;338:b26

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Peter B McIntyre, director1,
  2. Julia M L Brotherton, medical epidemiologist2,
  3. Margaret A Burgess, honorary professor3,
  4. Andrew S Kemp, professor of paediatric allergy3
  1. 1National Centre for Immunisation Research and Surveillance of Vaccine-Preventable Diseases, Royal Alexandra Hospital for Children, Westmead, Sydney, NSW 2145, Australia
  2. 2Victorian Cervical Cytology Register, PO Box 310, East Melbourne, VIC 8002, Australia
  3. 3University of Sydney and Royal Alexandra Hospital for Children, Westmead, Sydney
  1. peterm{at}chw.edu.au

    We concur with Kang and colleagues’ report on the school based quadrivalent human papillomavirus (HPV) vaccine programme in Victoria and South Australia that documented that IgE mediated hypersensitivity to the vaccine is rare.1 However, their case of a positive skin test result with generalised urticaria after the first dose and anaphylaxis after the second …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular